Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2013
02/05/2013US8367708 Phenyl-isoxazol-3-ol derivative
02/05/2013US8367707 Pest control agents
02/05/2013US8367706 Inhibitors of janus kinases
02/05/2013US8367705 Iminosugars and methods of treating bunyaviral and togaviral diseases
02/05/2013US8367704 Process for preparation of 2-methyl-2′ phenylpropionic acid derivatives and novel intermediate compounds
02/05/2013US8367703 Method of treating a sore throat
02/05/2013US8367702 Quinolone derivative
02/05/2013US8367701 Crystalline pharmaceutical and methods of preparation and use thereof
02/05/2013US8367700 Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
02/05/2013US8367699 Tetrahydro-isoquinolines
02/05/2013US8367698 3-substituted sulfonyl piperidine derivative
02/05/2013US8367696 Aza-bridged-ring compound
02/05/2013US8367695 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
02/05/2013US8367694 Carboline derivatives useful in the inhibition of angiogenesis
02/05/2013US8367693 Opioid salts and formulations exhibiting anti-abuse anti-dose dumping properties
02/05/2013US8367692 Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 tachikynin receptor antagonists
02/05/2013US8367691 Modulators of muscarinic receptors
02/05/2013US8367690 Aminopyridine derivatives having aurora a selective inhibitory action
02/05/2013US8367689 Inhibitors of JAK
02/05/2013US8367688 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
02/05/2013US8367687 Pyrazole derivatives
02/05/2013US8367686 Heterocycle compounds and uses thereof
02/05/2013US8367685 Stable pharmaceutical compositions comprising a pyrimidine-sulfamide
02/05/2013US8367684 Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
02/05/2013US8367683 Composition and method for treatment of warts
02/05/2013US8367681 Pyrazolopyrimidines and related heterocycles as kinase inhibitors
02/05/2013US8367680 Antibacterial small molecules and methods for their synthesis
02/05/2013US8367679 Biaryl carboxamides
02/05/2013US8367678 Treatment for spinal muscular atrophy
02/05/2013US8367677 Non-glycosylated/non-glycosidic/non-peptidic small molecule PSGL-1 mimetics for the treatment of inflammatory disorders
02/05/2013US8367676 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
02/05/2013US8367675 Compounds and method for treatment of cancer
02/05/2013US8367674 Piperazine derivatives
02/05/2013US8367673 Substituted diketopiperazines as oxytocin antagonists
02/05/2013US8367672 Pyridazine compounds, compositions and methods
02/05/2013US8367671 Pyrazolo[3.4-B]pyrazine compounds as p38 modulators and methods of use as anti-inflamatory agents
02/05/2013US8367670 Modulators of toll-like receptors
02/05/2013US8367669 Inhibitors of hemeprotein-catalyzed lipid peroxidation
02/05/2013US8367668 Pyridazinone derivatives
02/05/2013US8367667 Pyrrole derivatives as pharmaceutical agents
02/05/2013US8367666 3-carbamoyl-2-pyridone derivatives
02/05/2013US8367665 Estrogen receptor ligands
02/05/2013US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
02/05/2013US8367663 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
02/05/2013US8367662 Organic compounds
02/05/2013US8367661 Heterocyclic sulfonamides
02/05/2013US8367660 Modulators of cystic fibrosis transmembrane conductance regulator
02/05/2013US8367659 Oxazinyl isoflavonoid compounds, medicaments and use
02/05/2013US8367658 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
02/05/2013US8367657 Processes for preparing 3-benzazepines
02/05/2013US8367656 Polymorphs of 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid S,S-dioxide used to treat depressive disorders, irritable bowel syndrome, attention deficit hyperactivity disorder, asthma
02/05/2013US8367655 Pyridoindolobenzox—and thiazepine derivatives and uses thereof
02/05/2013US8367654 8-AZA tetracycline compounds
02/05/2013US8367653 Azetidinyl diamides as monoacylglycerol lipase inhibitors
02/05/2013US8367652 Methods of treating hypertriglyceridemia
02/05/2013US8367651 Solid ganaxolone formulations and methods for the making and use thereof
02/05/2013US8367650 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia
02/05/2013US8367649 Formulations of deoxycholic acid and salts thereof
02/05/2013US8367648 Substituted 16,17-annellated steroid compounds for use in womens healthcare
02/05/2013US8367647 Treatment of meconium aspiration syndrome with estrogens
02/05/2013US8367646 Steroid compounds and treatment methods
02/05/2013US8367645 Compositions and methods for treating hyperproliferative diseases
02/05/2013US8367644 Methods and compounds useful to induce apoptosis in cancer cells
02/05/2013US8367642 Methods of preventing or treating diseases and conditions using complex carbohydrates
02/05/2013US8367641 Use of modified oligo-β-(1,3)-glucans for treating diseases of the immune system, oligo-β-(1,3)-glucan-(1,3)-mannose, oligo-β-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them
02/05/2013US8367640 Complex consisted of a polysaccharide and an HBP
02/05/2013US8367639 Hydrogels with covalent and noncovalent crosslinks
02/05/2013US8367638 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
02/05/2013US8367637 Composition for treating arthritic disorder
02/05/2013US8367636 Therapy for skin disorders
02/05/2013US8367635 Antimicrobial sucralfate paste methods and compositions
02/05/2013US8367631 Pharmaceutical composition which improves in vivo gene transfer
02/05/2013US8367630 Method for inhibiting expression of a protein in a hepatocyte
02/05/2013US8367629 MCP-1 binding nucleic acids and use thereof
02/05/2013US8367625 Antibacterial aminoglycoside analogs
02/05/2013US8367624 Spraying, coating plants with aloe vera
02/05/2013US8367623 Glycolipid and medicine for autoimmune disease containing the same as active ingredient
02/05/2013US8367622 Sulfated C-glycoside, method for isolating same and method for synthesizing same
02/05/2013US8367605 Copolymer-1 improvements in compositions of copolymers
02/05/2013US8367603 Protein capable of inhibiting anthrax toxin activity
02/05/2013US8367418 Method and system to provide personalized pharmaceutical compositions and dosages
02/05/2013US8367360 Method of screening for inhibitors of tau protein phosphororylation by tyrosine kinase c-Abl
02/05/2013US8367118 Solid pharmaceutical dispersions with enhanced bioavailability
02/05/2013US8367116 Buoyant polymer particles for delivery of therapeutic agents to the central nervous system
02/05/2013US8367106 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
02/05/2013US8367105 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
02/05/2013US8367102 Pharmaceutical semi-solid composition of isotretinoin
02/05/2013US8367100 Preparation and use of sleeve and micro-encapsulated topical analgesic patch for treating pain
02/05/2013US8367097 Liquid formulations for treatment of diseases or conditions
02/05/2013US8367090 Coating on a balloon comprising a polymer and a drug
02/05/2013US8367088 Liquid pest control formulation
02/05/2013US8367086 Process and product for inhibiting or preventing bacterial infections
02/05/2013US8367084 Oily base for a cosmetic and cosmetic comprising the same
02/05/2013US8367081 Macrocyclic lactone compounds and methods for their use
02/05/2013US8367072 Composition for treating obesity and method of using the same
02/05/2013US8367070 Modified surface antigen
02/05/2013US8367065 Targeted polymeric prodrugs containing multifunctional linkers
02/05/2013US8367051 Preparation of functional gel particles with a dual crosslink network
02/05/2013CA2718231C Emulsions including a peg-derivative of tocopherol
02/05/2013CA2714085C Method of manufacture of 1,3-oxathiolane nucleosides